Boothbay Fund Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Boothbay Fund Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,419,080	Closed	-$1.76M	–	1697
2024 Q3	$1.76M	Buy	1,419,080 +39,728	+3%	+$49.7K	0.04%	561
2024 Q2	$2.3M	Buy	1,379,352 +1,001,083	+265%	+$1.79M	0.05%	455
2024 Q1	$704K	Buy	+378,269	New	+$697K	0.01%	884
2021 Q3	–	Sell	-5,096	Closed	-$428K	–	2034
2021 Q2	$428K	Sell	5,096 -24,867	-83%	-$1.64M	0.01%	1089
2021 Q1	$1.45M	Buy	29,963 +12,223	+69%	+$663K	0.05%	447
2020 Q4	$836K	Buy	17,740 +1,915	+12%	+$75.4K	0.03%	561
2020 Q3	$744K	Buy	+15,825	New	+$522K	0.05%	520

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EPL

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boothbay Fund Management's NBP Position: Q4 2024 in Review

Boothbay Fund Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2024, closing a stake of 1,419,080 shares — an estimated $1.76M sold.

Boothbay Fund Management first reported a position in NBP in Q3 2020 and held it in 7 quarters. The position peaked at $2.3M in Q2 2024. 28 funds tracked by Wall St. Rank hold NBP as of Q4 2024.

Boothbay Fund Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Boothbay Fund Management sold 1,419,080 NovaBridge Biosciences American Depositary Shares shares in Q4 2024, an estimated $1.76M.
Boothbay Fund Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 7 quarters.
Boothbay Fund Management's NovaBridge Biosciences American Depositary Shares position peaked at $2.3M in Q2 2024.
28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.